{
    "clinical_study": {
        "@rank": "134467", 
        "acronym": "Pro-HOPE", 
        "arm_group": {
            "arm_group_label": "helios stent", 
            "arm_group_type": "Experimental", 
            "description": "the group with helios stent implanted"
        }, 
        "brief_summary": {
            "textblock": "research topic:helios After registration of clinical research bidders:kinhely bio-tech\n      Co.Ltd study design:A prospective single treatment group multicenter clinical study Number\n      of patients:Included in the subjects of 800 cases Main research purpose:Evaluation of safety\n      and effectiveness Mainly studies the finish:1 year target lesion of the failure\n\n      Inclusion criteria :\n\n      one:Gender not limited at the age of 18 to 80 two:myocardial ischemia or angina symptoms of\n      coronary artery disease three:A narrow is less than 50% treated with stents four:Comply with\n      the instructions five:Voluntarily signed the informed consent form exclusion criteria:\n      one:Pregnant women two:cardiac shock three:Against a suppository medicines or allergies\n      four:Participated in other test research in the first 6 months five:Within 6 months after\n      PCI plans to accept non cardiac surgery six:Non-compliant patient Follow-up time:A month for\n      6 months and 9 months to 1 year to 2 years follow-up progress plan:All center within 6\n      months after start of complete into the group"
        }, 
        "brief_title": "A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "no desired"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Any age 18 to 80 sex Myocardial ischemia or angina pectoris of coronary artery\n             disease An application stents diameter stenosis greater than 50% Comply with the\n             instructions Voluntarily signed the informed consent form\n\n        Exclusion Criteria:\n\n          -  Pregnant women cardiac shock Intolerance to antithrombotic therapy or allergies 6\n             months prior to the start of the study involved in other studies Within 6 months\n             after PCI plans to accept non cardiac surgery Non-compliant patient"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "800", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01880879", 
            "org_study_id": "Pro-HOPE"
        }, 
        "intervention": {
            "arm_group_label": "helios stent", 
            "description": "the group with helios stent implanted", 
            "intervention_name": "helios stent", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "coronary artery disease", 
            "PCI", 
            "stent"
        ], 
        "lastchanged_date": "June 20, 2013", 
        "location": {
            "contact": {
                "email": "rjluqi@hotmail.com", 
                "last_name": "qi lu, chairman", 
                "phone": "+86-021-68383364", 
                "phone_ext": "68383006"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200127"
                }, 
                "name": "Yan chai hospital affiliated to Shanghai jiaotong university school of medicine"
            }, 
            "investigator": {
                "last_name": "ben he, chairman", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer Sirolimus-eluting Stent Safety and Effectiveness in Treatment of Coronary Artery Disease", 
        "other_outcome": {
            "description": "Stent placement in patients with the incidence of hospitalized again", 
            "measure": "Rehospitalization rate", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Target blood vessels caused by cardiac death and myocardial infarction and ischemia driven overall incidence of target lesion revascularization", 
            "measure": "1 year incidence of target lesion", 
            "safety_issue": "No", 
            "time_frame": "1year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01880879"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "22639432", 
            "citation": "Zhang T, Shen L, Hu L, He B. Optimal Duration of Dual-Antiplatelet Therapy Following Drug-Eluting Stent Implantation: A Meta-Analysis. J Clin Pharmacol. 2012 May 25. [Epub ahead of print] PubMed"
        }, 
        "secondary_outcome": [
            {
                "description": "Death and myocardial infarction and thromboembolism events and hospitalizations and the incidence of major adverse cardiac events as the standard for safety evaluation", 
                "measure": "cardiac death Target blood vessels caused by myocardial infarction Ischemia driven target lesion revascularization of 1 year and 2 years,MACE, Stent thrombosis events,clinical success.", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Cardiac death drive target blood vessels lead to myocardial infarction and ischemia of the incidence of target lesion revascularization", 
                "measure": "2 years, the incidence of various combination of the pathological changes of failure", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Kinhely Bio-tech Co.,Ltd.", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "RenJi Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Peking University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Kinhely Bio-tech Co.,Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}